期刊文献+

Enhancing the antihepatitis B virus immune response by adefovir dipivoxil and entecavir therapies 被引量:16

原文传递
导出
摘要 Chronicity of hepatitis B(CHB)infection is characterized by a weak immune response to the virus.Entecavir(ETV)and adefovir dipivoxil(ADV)are effective in suppressing hepatitis B virus(HBV)replication.However,the underlying immune mechanism in the antiviral response of patients treated with nucleoside or nucleotide analogs is not clearly understood.In this study,regulatory T cells(Tregs)and intracellular cytokines,including IL-2,interferon(IFN)-γ,tumor-necrosis factor(TNF)-α and IL-4,were measured prior to and at 12,24,36 and 48 weeks after treatment with ETV or ADV.The cytokines were increased from 24 to 48 weeks after treatment.Higher levels of Th1 cytokines were observed with ETV(n=29)versus ADV(n=28)treatment.By contrast,the numbers of Tregs in both groups were decreased.The altered cytokine profile and cellular component was accompanied by a decrease in HBV DNA levels in both groups,which may contribute to their therapeutic effect in CHB infection.Our findings suggest that the antiviral effect of the drugs may be attributed not only to their direct effect on virus suppression but also to their immunoregulatory capabilities.
出处 《Cellular & Molecular Immunology》 SCIE CAS CSCD 2011年第1期75-82,共8页 中国免疫学杂志(英文版)
基金 This work was supported by grants from the Eleventh Five-Year Plan for AIDS and viral hepatitis,prevention and treatment of infectious diseases and other major science and technology(No.2008ZX10002-004) the Ministry of Health Clinical Disciplines(No.20073531) the National Natural Science Foundation of China(No.30771912,30972610 and 30972611) Jilin Province Science and Technology Agency(No.200705128) a BMS grant for manuscript development.
关键词 ADV CYTOKINE ETV HBV Treg
  • 相关文献

参考文献3

二级参考文献37

  • 1Yoshihiro Furuichi,Hirotake Tokuyama,Satoshi Ueha,Makoto Kurachi,Fuminori Moriyasu,Kazuhiro Kakimi.Depletion of CD25^+CD4^+T cells (Tregs) enhances the HBV-specific CD8^+ T cell response primed by DNA immunization[J].World Journal of Gastroenterology,2005,11(24):3772-3777. 被引量:30
  • 2Yasuteru Kondo,Koju Kobayashi,Yoshiyuki Ueno,Masaaki Shiina,Hirofumi Niitsuma,Noriatsu Kanno,Tomoo Kobayashi,Tooru Shimosegawa.Mechanism of T cell hyporesponsiveness to HBcAg is associated with regulatory T cells in chronic hepatitis B[J].World Journal of Gastroenterology,2006,12(27):4310-4317. 被引量:16
  • 3Gish R.G.,王晓君.恩替卡韦与拉米夫定治疗HBeAg阳性慢性乙型肝炎的比较[J].世界核心医学期刊文摘(胃肠病学分册),2006,2(9):4-5. 被引量:9
  • 4Shouval D.,Lok A.S.,王晓君.恩替卡韦与拉米夫定治疗HBeAg阴性慢性乙型肝炎的比较[J].世界核心医学期刊文摘(胃肠病学分册),2006,2(9):5-6. 被引量:5
  • 5I-Che Feng,Lok-Beng Koay,Ming-Jen Sheu,Hsing-Tao Kuo,Chi-Shu Sun,Chuan Lee,Wong-Lung Chuang,Shuen-Kuei Liao,Shih-Ling Wang,Ling-Yu Tang,Chia-Ju Cheng,Sun-Lung Tsai.HBcAg-specific CD4+CD25+regulatory T cells modulate immune tolerance and acute exacerbation on the natural history of chronic hepatitis B virus infection[J].Journal of Biomedical Science.2007(1)
  • 6Deaglio S,Dwyer KM,Gao W,Friedman D,Usheva A,Erat A,Chen JF,Enjyoji K,Linden J,Oukka M,Kuchroo VK,Strom TB,Robson SC.Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune sup- pression[].J Exp Med.2007
  • 7Campbell DJ,Ziegler SF.FOXP3 modifies the phenotypic and functional properties of regulatory T cells[].Nature Reviews Immunology.2007
  • 8Marson A,Kretschmer K,Frampton GM,Jacobsen ES,Po- lansky JK,MacIsaac KD,Levine SS,Fraenkel E,von Boehmer H,Young RA.Foxp3 occupancy and regulation of key target genes during T-cell stimulation[].Nature.2007
  • 9Zheng Y,Josefowicz SZ,Kas A,Chu TT,Gavin MA,Rudensky AY.Genome-wide analysis of Foxp3 target genes in develo- ping and mature regulatory T cells[].Nature.2007
  • 10Klenerman P,Hill A.T cells and viral persistence: lessons from diverse infections[].Nature Immunology.2005

共引文献44

同被引文献90

引证文献16

二级引证文献160

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部